AVTX

Avalo Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

32.2%

Short % Float

14.4d to cover · High squeeze

1.3%

Inst % Float

10 holders · 2026-06-30

FMR, LLC

Top Holder

9.5% of float

40.2M sh

Public Float

-7.1% chg

61/100

Dilution Score

High

23 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

61/100

HIGH

Inst: 1.33% · Top: FMR, LLC

Biotech Analytics

Biotech / Pharma

15.69

Dilution Risk: HIGHSqueeze risk: HIGHBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk61

Clinical Trials0

Short Interest90